Table 4.

Death, stroke, or myocardial infarction within 30 days of stent procedure

		Total (n=1564) No. (%)	Women (n=579) No. (%)	Men (n=985) No. (%)
Death	Asymptomatic	6 (0.5%)	2 (0.5%)	4 (0.6%)
	Symptomatic	6 (1.5%)	4 (2.8%)	2 (0.7%)
	Total	12 (0.8%)	6 (1.0%)	6 (0.6%)
Stroke	Asymptomatic	41 (3.6%)	18 (4.1%)	23 (3.2%)
	Symptomatic	21 (5.1%)	7 (4.9%)	14 (5.2%)
	Total	62 (4.0%)	25 (4.3%)	37 (3.8%)
Death or stroke	Asymptomatic	43 (3.7%)	18 (4.1%)	25 (3.5%)
	Symptomatic	24 (5.8%)	8 (5.6%)	16 (5.9%)
	Total	67 (4.3%)	26 (4.5%)	41 (4.2%)
MI	Asymptomatic	14 (1.2%)	8 (1.8%)	6 (0.8%)
	Symptomatic	1 (0.2%)	1 (0.7%)	0 (0.0%)
	Total	15 (1.0%)	9 (1.6%)	6 (0.6%)
Death, stroke, MI	Asymptomatic	55 (4.8%)	24 (5.5%)	31 (4.4%)
	Symptomatic	25 (6.0%)	9 (6.3%)	16 (5.9%)
	Total	80 (5.1%)	33 (5.7%)	47 (4.8%)

All differences non-significant, p > .05.